|
OPT
|
Opthea Limited
|
US
|
NASDAQ
|
|
ORGO
|
Organogenesis Holdings Inc.
|
US
|
NASDAQ
|
|
ORGS
|
Orgenesis Inc.
|
US
|
NASDAQ
|
|
ORPHA
|
Orphazyme A/S
|
DK
|
CO
|
|
ORTX
|
Orchard Therapeutics plc
|
US
|
NASDAQ
|
|
ORY
|
Oryzon Genomics SA
|
ES
|
MC
|
|
OSE
|
OSE Pharma SA
|
FR
|
PA
|
|
OSTX
|
OS Therapies Incorporated
|
US
|
US
|
|
OTLK
|
Outlook Therapeutics, Inc.
|
US
|
NASDAQ
|
|
OVID
|
Ovid Therapeutics Inc.
|
US
|
NASDAQ
|
|
OVIT
|
Oncovista Innovative Therapies I
|
US
|
OTC
|
|
OXB
|
Oxford Biomedica Plc
|
UK
|
LSE
|
|
OYST
|
Oyster Point Pharma, Inc.
|
US
|
NASDAQ
|
|
PAB
|
Patrys Limited
|
AU
|
ASX
|
|
PANC
|
Panacos Pharmaceuticals Inc
|
US
|
US
|
|
PANG
|
Pangaea Oncology S.A.
|
ES
|
MC
|
|
PAR
|
Paradigm Biopharmaceuticals Ltd
|
AU
|
ASX
|
|
PARD
|
Poniard Pharmaceuticals Inc
|
US
|
US
|
|
PBLA
|
Panbela Therapeutics, Inc.
|
US
|
NASDAQ
|
|
PBM
|
Psyence Biomedical Ltd. Common Shares
|
US
|
US
|